Table 1.
General characteristics of the participants
| Variables | Total (n=155) | Male (n=77) | Female (n=78) | P |
|---|---|---|---|---|
| Age (years) | 53.03±9.98 | 52.39±10.42 | 53.64±9.55 | 0.44 |
| Weight (kg) | 80.46±12.47 | 85.93±11.86 | 75.21±10.71 | <0.001 |
| BMI (kg/m2) | 29.64±3.80 | 28.67±3.37 | 30.57±3.97 | 0.002 |
| WC (cm) | 101.08±7.48 | 99.23±6.02 | 102.70±8.26 | 0.006 |
| WHR | 0.97±0.05 | 0.98±0.04 | 0.96±0.05 | 0.07 |
| SBP (mmHg) | 13.42±2.23 | 13.78±1.97 | 13.06±2.41 | 0.04 |
| DBP (mmHg) | 8.52±1.36 | 8.86±1.34 | 8.19±1.31 | 0.002 |
| HR (n) | 84.66±11.98 | 82.83±12.40 | 86.44±11.36 | 0.07 |
| MAP | 10.15±1.55 | 10.50±1.49 | 9.81±1.55 | 0.006 |
| TG (mg/dl) | 190.11±104.89 | 199.10±120.20 | 181.23±87.08 | 0.29 |
| HDL (mg/dl) | 48.77±9.49 | 45.87±6.54 | 51.63±11.02 | <0.001 |
| LDL (mg/dl) | 76.49±28.54 | 75.24±28.66 | 77.68±28.56 | 0.60 |
| Cholesterol (mg/dl) | 161.63±38.70 | 157.19±38.28 | 166.01±38.87 | 0.15 |
| VLDL (mg/dl) | 38.35±21.96 | 40.48±25.59 | 36.25±17.59 | 0.23 |
| AIP | 0.54±0.25 | 0.57±0.25 | 0.51±0.25 | 0.08 |
| FBS (mg/l) | 176.79±65.97 | 169.52±57.91 | 183.97±72.73 | 0.17 |
| Insulin (ng/dl) | 13.09±6.04 | 13.20±5.55 | 12.99±6.50 | 0.83 |
| HOMA-IR | 5.62±3.31 | 5.56±3.18 | 5.67±3.43 | 0.85 |
| hs-CRP (mg/l) | 3.88±0.84 | 3.81±0.63 | 3.95±0.99 | 0.32 |
| IL-6 (ng/dl) | 2.02±1.53 | 1.99±1.65 | 2.04±1.42 | 0.85 |
| TAC | 0.39±0.12 | 0.42±0.10 | 0.38±0.14 | 0.03 |
BMI=Body mass index; WC=Waist circumference; WHR=Waist-to-hip ratio; SBP=Systolic blood pressure; DBP=Diastolic blood pressure; HR=Heart rat; MAP=Mean arterial pressure; TG=Triglyceride; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; VLDL=Very-LDL; AIP=Atherogenic index of plasma; FBS=Fasting blood sugar; HOMA-IR=Homeostatic model assessment of insulin resistance; hs-CRP=High-sensitivity C-reactive protein; IL-6: Interleukin-6; TAC: Total antioxidant capacity